Seems very conservative to me, considering back in January, it surged over $4.00 on a rumor about the lung cancer results. Here's my current feelings about the potential, based on nothing more than some logic and a desire for this to happen: SPA, up to/around $5.00, SPA, good trial results, $7.00 (Roth), and added partnership(s), $12.00 to $15.00. Buyout offer, $30-$40, low end.
Thoughts anybody? I really feel this will take off, with a little good news,
We're all just giving our opinions, so there's no wrong answer.
July is only a few weeks away. If we get to $5, I'll be happy. Heck yes, that will mean a huge jump in my net worth! (I'm overweighted in CYCC, to say the least.)
But based on the Sanofi deal with Ascenta, I believe I have underestimated how big of a deal we might get. So I don't want to underestimate how far the price can run.
Medarex went from $2 to a $16 buyout in about 6 months. With their positive news today, I'll bet that no BMY shareholders are whining that they overpaid.
I owned Medarex when they got the buyout. So I'm not shooting from the hip when I say I think CYCC is a superior company. Medarex got over $2 billion - and had nothing out of phase 2.
So if people think Rich is too optimistic on a $30 buyout, that's only a little over $1 billion - half of what Medarex got. How do you think the people who sold Medarex for $2 in January (last year) felt when it was $16 in July?Or the people who sold at $4 because they had doubled their money and they didn't want to be greedy. After all, "hogs get slaughtered."
Who knows what will happen, I know I don't. But I wouldn't use the current stock price as a guide to the future price. But OK, before we talk $30, let's get the frickin' price over $3 first!